Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01ZDR
|
||||
Former ID |
DIB011410
|
||||
Drug Name |
FR-208419
|
||||
Synonyms |
IDDB16886
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Dyspepsia [ICD9: 536.8; ICD10:K30] | Terminated | [1] | ||
Company |
Fujisawa Pharmaceutical Co Ltd
|
||||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C28H34N4O3
|
||||
Canonical SMILES |
N1(c2c(C(=N[C@H](NC(=O)Nc3cc(ccc3)C)C1)CC)cccc2C)CC(=O)<br />C1CCCCC1
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Gastrin/cholecystokinin type B receptor | Target Info | Modulator | [2] | |
Cholecystokinin receptor type A | Target Info | Modulator | [2] | ||
KEGG Pathway | Calcium signaling pathway | ||||
Neuroactive ligand-receptor interaction | |||||
Gastric acid secretionhsa04020:Calcium signaling pathway | |||||
Insulin secretion | |||||
Pancreatic secretion | |||||
PANTHER Pathway | CCKR signaling map ST | ||||
PathWhiz Pathway | Gastric Acid Production | ||||
Reactome | Peptide ligand-binding receptors | ||||
G alpha (q) signalling events | |||||
Gastrin-CREB signalling pathway via PKC and MAPKR-HSA-375276:Peptide ligand-binding receptors | |||||
WikiPathways | GPCRs, Class A Rhodopsin-like | ||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
Secretion of Hydrochloric Acid in Parietal Cells | |||||
Peptide GPCRs | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
GPCRs, OtherWP455:GPCRs, Class A Rhodopsin-like | |||||
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010485) | ||||
REF 2 | Dual CCK-A and CCK-B receptor antagonists (II). Preparation and structure activity relationships of 5-alkyl-9-methyl-1,4-benzodiazepines and discovery of FR208419. Chem Pharm Bull (Tokyo). 2000 Jan;48(1):1-15. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.